- ￥2000 - 8000
- 湖北省武汉市
- Mouse Slc22a18重组蛋白表达
- 2025年09月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 服务名称：
大肠杆菌系统重组蛋白表达
- 提供商：
普健生物（武汉）科技有限公司
Uniprot号：Q78KK3
基因名：Slc22a18
蛋白名：Solute carrier family 22 member 18
蛋白别名：
Solute carrier family 22 member 18, Imprinted multi-membrane-spanning polyspecific transporter-related protein 1, Multi-membrane-spanning polyspecific transporter, Organic cation transporter-like protein 2, ORCTL-2
服务内容：
| 服务项目 | 客户提供 | 服务内容 | 服务周期 | 交付内容 |
|---|---|---|---|---|
| 大肠杆菌系统 蛋白表达 |
基因序列 | 方案沟通 | 1天 | 方案报告 |
| 密码子优化和基因合成 | 5天 | 基因合成报告 | ||
| 表达纯化测试 | 3天 | 表达纯化测试报告 | ||
| 1L表达及纯化 | 3天 | 蛋白样品(3-5mg)及报告 | ||
| 放大发酵及纯化 | 7天 | 纯化的蛋白及报告 |
案例展示：
Slc22a18相关研究文献：
1. Overexpression of Slc22a18 facilitates fat accumulation in mice. [38626531]
2. Expression of SLC22A18 regulates oxaliplatin resistance by modulating the ERK pathway in colorectal cancer. [35411243]
3. Knockdown of Orphan Transporter SLC22A18 Impairs Lipid Metabolism and Increases Invasiveness of HepG2 Cells. [30635741]
4. Correlation of low SLC22A18 expression with poor prognosis in patients with glioma. [22153794]
5. The Roles of Imprinted SLC22A18 and SLC22A18AS Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients. [32726996]
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验2. Expression of SLC22A18 regulates oxaliplatin resistance by modulating the ERK pathway in colorectal cancer. [35411243]
3. Knockdown of Orphan Transporter SLC22A18 Impairs Lipid Metabolism and Increases Invasiveness of HepG2 Cells. [30635741]
4. Correlation of low SLC22A18 expression with poor prognosis in patients with glioma. [22153794]
5. The Roles of Imprinted SLC22A18 and SLC22A18AS Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients. [32726996]
技术资料暂无技术资料 索取技术资料
